Bio Protocol vs Convex Finance — how do they compare? Bio Protocol trades at Rp513.72 (market cap Rp1,15T, Rp260,42M 24h volume), while Convex Finance trades at Rp22,751 (market cap Rp2,24T, Rp111,34M 24h volume). The key difference: Convex Finance is the larger of the two by market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Convex Finance's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Convex Finance for 29 Days on average.
| BIO | CVX | |
|---|---|---|
Market Cap | Rp1,15T | Rp2,24T |
Volume (24h) | Rp260,42M | Rp111,34M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 98,7M CVX |
Typical Hold Time | 16 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Convex Finance (CVX) is currently trading at Rp22,100 with a market cap of Rp2.18 trillion, showing bullish technical signals with strong moving average support. The token is positioned above key support levels with RSI indicators in neutral territory, suggesting potential for upward momentum. Recent ecosystem activity includes ongoing protocol optimizations and yield farming opportunities within the DeFi space.
Overall outlook remains cautiously optimistic with technical indicators favoring bulls, though neutral oscillators suggest potential consolidation. Key opportunities include DeFi yield optimization growth, while risks involve typical crypto volatility and regulatory uncertainty. Investors should monitor support at Rp21,923 and resistance at Rp23,245 for near-term direction.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Convex Finance is a DeFi protocol that allows Curve liquidity providers to earn a share of trading fees on Curve without staking liquidity there.
Read more on CVX →